Tessella’s Tom Parke, Head of Clinical Technologies, will be holding three separate talks at the DIA 23rd Annual Euro Meeting, taking place on March 28-30th, 2011, Geneva, Switzerland. Tom’s topics are: Incorporating biomarker data in clinical trials for developing personalised medicine Commercial Software Solutions for Exploratory Studies Using simulations to communicate the expected consequences of planned statistical analyses To find [...]

Today The Telegraph published an article about drug and cosmetic firms planning to cut back on animal testing, click here to see full article.  The time is right for a big push in this area with affordable computing power, sophisticated computer models based on many years’ experience and huge quantities of experimental data now all available. Success [...]

Tessella are sponsoring this year’s 2010 Accelrys European User Group Meeting, taking place at the Dolce Sitges Hotel in Barcelona, Spain on October 26-28th 2010. Mark Roberts from Tessella and Ed Ainscow from AstraZeneca will be speaking at the event.  The title of their abstract is ‘A Flexible Platform for Processing High-Content Screening Data’ which [...]

Register for our live webcast on Tuesday, 8 June 2010 08:00 (PDT) 11:00 (EDT) 16:00 (BST)  17:00 (CEST) Join Tom Parke as he quizzes adaptive trial gurus Prof. Don Berry and Dr. Scott Berry on the implications of the recent FDA Guidance on Adaptive Design for Clinical Trials. Tom will be getting answers to the key [...]

The FACTS User Group Meeting will be taking place on July 20th and 21st 2010 at Le Meridien, Cambridge, Massachusetts, USA. For further information about this event, please email info@tessella.com. For information about FACTS and clinical trial solutions, visit www.smarterclinicaltrials.com

Major changes to the way cancer drugs are tested in people could lead to better and cheaper therapies coming to the market more quickly…read more

Faced with the challenge of falling success rates in drug development, clinical development teams must find new ways forward. Tessella and Berry Consultants believe that designing smarter clinical trials is part of the solution. We believe that better trial design can help: • Maximize the impact of your clinical trials on your drug development process. [...]

Yili Pritchett of Abbott was able to show real data from a trial we ran for them between 2007-2009. Read more.

The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue [...]

Quick ‘bench-to-bedside’ clinical trial would enroll 1,400 influenza patients to test corticosteroids and statins as potential treatments TORONTO, Ont., November 10, 2009 — An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic. Read more ….